Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$2.45
-0.22-8.41%
Last update: Oct 2, 4:00 PM
$2.44
-0.23-8.79%
Voyager Therapeutics Inc (VYGR) Stock Price, Quote, News & History
VYGRNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA;...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Voyager Therapeutics (NASDAQ:VYGR) through any online brokerage.
Other companies in Voyager Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Voyager Therapeutics has a consensus price target of $15.91.
The stock price for Voyager Therapeutics (NASDAQ: VYGR) is $2.44 last updated October 2, 2026 at 4:00 PM EDT.
There are no upcoming dividends for Voyager Therapeutics.
Voyager Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Voyager Therapeutics.
Voyager Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
